These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24911493)

  • 1. Behind closed doors.
    DeFrancesco L
    Nat Biotechnol; 2014 Jun; 32(6):528-35. PubMed ID: 24911493
    [No Abstract]   [Full Text] [Related]  

  • 2. Expose your clinical thinking.
    Nat Biotechnol; 2004 Aug; 22(8):927. PubMed ID: 15286628
    [No Abstract]   [Full Text] [Related]  

  • 3. North American regulatory agencies can and should make clinical trial data publicly available.
    Persaud N; Doshi P
    CMAJ; 2016 Feb; 188(2):96-97. PubMed ID: 26464136
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugmakers prefer silence on test data; firms violate US law by not registering trials.
    Vedantam S
    Washington Post; 2004 Jul; ():A1, A4. PubMed ID: 15290815
    [No Abstract]   [Full Text] [Related]  

  • 5. Stronger sanctions needed against companies that suppress data.
    Roehr B
    BMJ; 2004 Jul; 329(7458):132. PubMed ID: 15258068
    [No Abstract]   [Full Text] [Related]  

  • 6. European drug agency to appeal ruling that it stop releasing trial data.
    Hawkes N
    BMJ; 2016 Sep; 354():i5331. PubMed ID: 27694255
    [No Abstract]   [Full Text] [Related]  

  • 7. New European clinical trial regulations are "unacceptable" to industry.
    Davidson S
    Nat Biotechnol; 1998 Feb; 16(2):127. PubMed ID: 9487504
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trial data: to disclose or not to disclose?
    Bouchie A
    Nat Biotechnol; 2006 Sep; 24(9):1058-60. PubMed ID: 16964203
    [No Abstract]   [Full Text] [Related]  

  • 9. Government regulators must steward drug transparency.
    Herder M
    Nat Med; 2014 Aug; 20(8):806. PubMed ID: 25100518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pioneers of transparency.
    Adams B
    BMJ; 2015 Jan; 350():g7717. PubMed ID: 25555823
    [No Abstract]   [Full Text] [Related]  

  • 11. Best-kept secrets.
    Nat Biotechnol; 2014 Jun; 32(6):499. PubMed ID: 24911473
    [No Abstract]   [Full Text] [Related]  

  • 12. A new prescription for drug industry.
    Dean M
    Lancet; 1993 Apr; 341(8849):883-4. PubMed ID: 8096577
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictable materiality: a need for common criteria governing the disclosure of clinical trial results by publicly-traded pharmaceutical companies.
    Cohen K; Cormier JW; Davar MV
    J Contemp Health Law Policy; 2013; 29(2):201-32. PubMed ID: 23837261
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trial transparency--antidote to weaker off-label-promotion rules?
    Outterson K
    N Engl J Med; 2014 Jul; 371(1):1-3. PubMed ID: 24988551
    [No Abstract]   [Full Text] [Related]  

  • 15. Out in the open.
    Nat Biotechnol; 2005 Feb; 23(2):153. PubMed ID: 15696130
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trial data: share and share alike?
    Mitka M
    JAMA; 2015 Mar; 313(9):881-2. PubMed ID: 25734721
    [No Abstract]   [Full Text] [Related]  

  • 17. Good pharma? Bad pharma? Better pharma.
    Hardman M
    J R Coll Physicians Edinb; 2014; 44(4):269-72. PubMed ID: 25516893
    [No Abstract]   [Full Text] [Related]  

  • 18. Glaxo agrees to post results of drug trials on web site.
    Harris G
    N Y Times Web; 2004 Aug; ():C4. PubMed ID: 15540364
    [No Abstract]   [Full Text] [Related]  

  • 19. Investment managers back greater transparency of clinical trials.
    Hawkes N
    BMJ; 2015 Jul; 351():h4002. PubMed ID: 26207007
    [No Abstract]   [Full Text] [Related]  

  • 20. European ombudsman questions European Medicines Agency over AbbVie redactions.
    Watson R
    BMJ; 2014 Nov; 349():g6904. PubMed ID: 25406123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.